PMID- 20514596 OWN - NLM STAT- MEDLINE DCOM- 20100701 LR - 20201209 IS - 1439-4413 (Electronic) IS - 0012-0472 (Linking) VI - 135 IP - 23 DP - 2010 Jun TI - [HIV-therapy-associated immune reconstitution syndrome presenting as immunogenic hyperthyroidism]. PG - 1171-4 LID - 10.1055/s-0030-1255125 [doi] AB - HISTORY AND CLINICAL FINDINGS: A 51-year-old man infected with HIV-1 presented with weight loss, weakness, fever, agitation, tachycardia and tremor first occurring three year after initiation of antiretroviral therapy. INVESTIGATIONS: The electrocardiogram showed atrial fibrillation. Laboratory findings revealed hyperthyroidism with fully suppressed thyroid stimulating hormone (TSH). Antibodies against thyroid globulin and TSH-receptor were markedly increased. Both alpha-fodrin antibodies and antinuclear antibodies were abnormal. Retrospective analysis revealed an association of hyperthyroidism and the presence of autoantibodies with a sudden immune reconstitution under HIV-therapy. DIAGNOSIS, TREATMENT AND COURSE: An immune reconstitution inflammatory syndrome (IRIS) presenting as Graves's disease was diagnosed and treated with radioiodide. The patient recovered to clinical euthyroidism while antiretroviral treatment remained unchanged. CONCLUSION: IRIS against infectious or self-antigens during HIV treatment results from local or systemic inflammatory imbalances. IRIS with autoimmune manifestations may occur even years after initiation of an effective antiretroviral therapy. CI - Georg Thieme Verlag KG Stuttgart, New York. FAU - Ho, N A H AU - Ho NA AD - Klinik fur Immunologie und Rheumatologie, Medizinische Hochschule Hannover. FAU - Schmidt, R E AU - Schmidt RE FAU - Behrens, G AU - Behrens G LA - ger PT - Case Reports PT - Journal Article TT - Immunogene Hyperthyreose als Immunrekonstitutionssyndrom unter HIV-Therapie. DEP - 20100531 PL - Germany TA - Dtsch Med Wochenschr JT - Deutsche medizinische Wochenschrift (1946) JID - 0006723 RN - 0 (Alkynes) RN - 0 (Anti-HIV Agents) RN - 0 (Autoantibodies) RN - 0 (Benzoxazines) RN - 0 (Cyclopropanes) RN - 0 (Organophosphonates) RN - 0W860991D6 (Deoxycytidine) RN - 99YXE507IL (Tenofovir) RN - G70B4ETF4S (Emtricitabine) RN - JAC85A2161 (Adenine) RN - JE6H2O27P8 (efavirenz) SB - IM MH - Adenine/adverse effects/*analogs & derivatives/therapeutic use MH - Alkynes MH - Anti-HIV Agents/*adverse effects/therapeutic use MH - Autoantibodies/blood MH - Benzoxazines/*adverse effects/therapeutic use MH - Cyclopropanes MH - Deoxycytidine/adverse effects/*analogs & derivatives/therapeutic use MH - Diagnosis, Differential MH - Drug Therapy, Combination MH - Emtricitabine MH - Graves Disease/chemically induced/diagnosis/immunology MH - HIV Infections/*drug therapy/immunology MH - *HIV-1 MH - Humans MH - Immune Reconstitution Inflammatory Syndrome/*chemically induced/diagnosis/immunology MH - Long-Term Care MH - Male MH - Middle Aged MH - Organophosphonates/*adverse effects/therapeutic use MH - Tenofovir MH - Thyroid Gland/immunology MH - Thyroiditis, Autoimmune/*chemically induced/diagnosis/immunology EDAT- 2010/06/02 06:00 MHDA- 2010/07/02 06:00 CRDT- 2010/06/02 06:00 PHST- 2010/06/02 06:00 [entrez] PHST- 2010/06/02 06:00 [pubmed] PHST- 2010/07/02 06:00 [medline] AID - 10.1055/s-0030-1255125 [doi] PST - ppublish SO - Dtsch Med Wochenschr. 2010 Jun;135(23):1171-4. doi: 10.1055/s-0030-1255125. Epub 2010 May 31.